Navigation Links
FDA Approves Updated, Clarified Indication for Use for iFuse Implant System®
Date:4/25/2011

SAN JOSE, Calif., April 25, 2011 /PRNewswire/ -- SI-BONE, Inc. (San Jose, California), a medical device company that is pioneering the use of a minimally invasive surgical (MIS) device to treat the sacroiliac (SI) joint announced the U.S. Food and Drug Administration (FDA) approved a major modification to the existing product label. The Approval targets the use of iFuse Implant System® for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.

In the spirit of collaboration, FDA-OSDB worked with SI-BONE, Inc. to arrive at a more accurate description of the intended use of the iFuse System. The communications were helpful in differentiating the iFuse System from fracture fixation devices. Based upon internal discussions, as well as a review of the medical literature related to SI joint disease and associated clinical care, FDA agreed to remove "fracture" from the indications for use and to further modify the indications for use statement as follows: "The SI Joint Fusion System is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis, as the Agency believed this is more in line with the true intent of SI Joint Fusion System."

Commenting on the FDA approval of SI-BONE's 510(K), CEO, Jeff Dunn said, "This approval from the Agency provides us with a significant advantage in getting the word out on appropriate diagnosis of low back complaints that include the SI joint and that an MIS option for patients with SI joint problems and provides us with a unique opportunity to teach spine surgeons about the iFuse Implant System for SI joint fixation/fusion."

Barbara Bunger, Vice President, Clinical, Regulatory and Quality at SI-BONE stated, "It's important for companies, like SI-BONE, Inc., to work closely with the FDA in developing solutions for patients with low back complaints due to the SI joint and the company looks for
'/>"/>

SOURCE SI-BONE, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)...  Diplomat, the nation,s largest independent specialty pharmacy, ... in the 2014 Innovations in Specialty Pharmacy Competition, ... of the competition were announced in the August ... Diplomat was honored as a Top Innovator ... Through Diplomat University, the company has implemented a ...
(Date:8/22/2014)... Ohio , Aug. 22, 2014 MC Medical, ... Inc. (MID), a Columbus, OH medical ... distribute the FloShield laparoscopic and robotic visualization system in ... be approved for sale in Japan ... a long-time experience and an extensive product portfolio in endoscopic ...
(Date:8/22/2014)... , Aug. 22, 2014  Mark Riccio, director ... imaging facility, is using the online crowd-funding platform ... 5D imaging to researchers and would-be superheros everywhere: ... "What would YOU do if you had Superman,s ... researchers and explorers everywhere, from elementary through high ...
Breaking Medicine Technology:Diplomat honored as a Top Innovator by Specialty Pharmacy News 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2
... 16, 2011 Vista Partners announced today that ... CDY) (the "Company") and raised its twelve month target price ... stated, "Cellmid is on track to enter clinical trials for ... the billions. The Company recently completed humanisation of its "first ...
... The federal government,s tracking system for power wheelchairs ... for a new procurement policy implemented last January. Thus, ... of power wheelchairs provided than were actually delivered to ... report declines of 30 percent or more in their ...
Cached Medicine Technology:Vista Partners Updates Coverage on Cellmid Limited; Raises Target Price to AUD $0.12 2American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 2American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 3American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 4
(Date:8/23/2014)... August 23, 2014 A team of New ... last longer when preceded by surgery and delivered by an ... the new study. Click here to read it now ... the cases of mesothelioma patients who underwent hemithoracic ... radiotherapy dose to the shape of a tumor. Patients ...
(Date:8/23/2014)... 2014 The MPWMD Board of Directors voted ... as a sole source of water for commercial and industrial ... architect, Ron Brown of Archworks, LLC in Carmel, California. ... first time a water district in the State of California ... source. AWGs at this time can now be used ...
(Date:8/23/2014)... 23, 2014 Youth substance abuse is ... no different in Houston, TX. Substance abuse can happen ... to drug and alcohol dependency in higher numbers than ... beat substance abuse, but don’t know where to find ... can be a challenge because most treatment options are ...
(Date:8/22/2014)... The IT manager of Top10BestSEOHosting.com is a web ... He has recently announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ) ... , GoDaddy is a popular supplier of cheap web ... solutions at affordable rates. It offers three Linux shared ... depend on the length of the contract. The longest ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 AWeber, ... services that currently helps more than 120,000 small ... caught the attention of Shane Michaels, prompting an investigative ... crucial element for any online marketing campaign, despite what ... in the marketing world,” reports Michaels. “AWeber is a ...
Breaking Medicine News(10 mins):Health News:New Study Links Hospital Experience and Prior Surgery with Mesothelioma Radiation Success, According to Surviving Mesothelioma 2Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:New Houston Hotline Assisting Juveniles in Locating Dependable Rehabilitation Help 2Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2
... cord blood are to be used for regeneration of broken ... €2.5 million to be headed by York University and // ... researchers from department of biology, sociology and Philosophy from York ... blood stem cells in the treatment of bone defects and ...
... as eliminated Leprosy but still we have to eradicate the ... the awareness regarding the // transmission of the bacteria and ... ,Indian Health Minister Dr. Anbumani Ramadoss during the ... eradicate the disease which as about a 1 Lakh of ...
... in New South Wales are angry at a proposal to cut ... spokesman for the medical staff council at Wagga // Base Hospital, ... surgery every fourth Friday. ,"So it'd create a long ... small amount of money but at great cost to patient care," ...
... by researchers from University of Texas has revealed that ... can work wonders in easing depression. // Other ... alcohol, caffeine or smoking are associated with adverse health ... a group of 40 individuals, diagnosed with depression. None ...
... ever study conducted on the prevalence of diabetes in the ... diabetes has been uncovered. // So far, such studies ... which cannot be applied to South Asians. ,The ... and Diabetes Research Centre, an association of the World Health ...
... magnetic resonance imaging (fMRI) can help identify if an ... traditional polygraph tests. // The test further highlights certain ... tells a lie. Researchers from Temple University Hospital in ... in the latest issue of Radiology. ,The ...
Cached Medicine News:Health News:Prevention And Control Of Diabetes Crucial To Indian Population 2Health News:Brain Is More Active While Hiding The Truth, Reveals fMRI Imaging 2
For the quantitative determination of alanine aminotransferase in human serum....
... for the quantitative determination of ... or plasma. Single vial, dry ... must be purchased separately for ... reaction. Wavelength: 340 nm. Linearity: ...
Urea nitrogen (BUN) liquid reagent is used for the kinetic quantitative determination of Urea Nitrogen (BUN) in human serum used in routine examination and monitoring of therapy and relapses....
Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C....
Medicine Products: